Linked Life Data

18334238

Source:http://linkedlifedata.com/resource/pubmed/id/18334238

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-3-12
pubmed:abstractText
Since 2006, end-stage renal disease (ESRD) patients enrolled in Medicare are also eligible to enroll in the voluntary prescription drug program, Medicare Part D, which is administered by private sector entities called prescription drug plans (PDPs) or Medicare Advantage Part D plans. Approximately 84% of ESRD patients should be eligible to receive Part D benefits based on Medicare coverage, but the percentage who lack adequate prescription coverage and are enrolled is unclear. Dually eligible (Medicare and Medicaid) ESRD patients were automatically enrolled in PDPs if they did not self-enroll. Many experienced problems after Part D implementation, including interruptions in prescription drug coverage, formulary issues, and difficulties when seeking appeals. Several key ESRD medications are not covered by Part D plans. Trade-name ESRD medications are often placed in higher formulary tiers requiring higher copayment. Enhanced plans covering more medications require higher premiums. ESRD patients have higher out-of-pocket expenses under Part D than general Medicare patients and are more likely to reach and go through the coverage gap and to reach catastrophic coverage. The complexities of Medicare Part D make problems inevitable; ESRD patients may be more vulnerable to these problems than the general Medicare population, but further data are needed.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1548-5609
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
140-6
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Potential impact of Medicare Part D in the end-stage renal disease population.
pubmed:affiliation
College of Pharmacy, University of Minnesota, Minneapolis, MN, USA. WStPeter@cdrg.org
pubmed:publicationType
Journal Article, Review